Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Schizophrenia

  Free Subscription


Articles published in Acta Psychiatr Scand

Retrieve available abstracts of 40 articles:
HTML format
Text format



Single Articles


    December 2018
  1. ONWORDI E, Howes O
    Trends in mortality in schizophrenia and their implications.
    Acta Psychiatr Scand. 2018;138:489-491.
    PubMed     Text format    


    October 2018
  2. OKHUIJSEN-PFEIFER C, Huijsman EAH, Hasan A, Sommer IEC, et al
    Clozapine as a first- or second-line treatment in schizophrenia: a systematic review and meta-analysis.
    Acta Psychiatr Scand. 2018;138:281-288.
    PubMed     Text format     Abstract available


    September 2018
  3. DE NIJS J, Schnack HG, Koevoets MGJC, Kubota M, et al
    Reward-related brain structures are smaller in patients with schizophrenia and comorbid metabolic syndrome.
    Acta Psychiatr Scand. 2018 Sep 27. doi: 10.1111/acps.12955.
    PubMed     Text format     Abstract available


  4. DE PIERREFEU A, Lofstedt T, Laidi C, Hadj-Selem F, et al
    Identifying a neuroanatomical signature of schizophrenia, reproducible across sites and stages, using machine learning with structured sparsity.
    Acta Psychiatr Scand. 2018 Sep 21. doi: 10.1111/acps.12964.
    PubMed     Text format     Abstract available


  5. ISLAM MA, Habtewold TD, van Es FD, Quee PJ, et al
    Long-term cognitive trajectories and heterogeneity in patients with schizophrenia and their unaffected siblings.
    Acta Psychiatr Scand. 2018 Sep 21. doi: 10.1111/acps.12961.
    PubMed     Text format     Abstract available


  6. BERRY N, Emsley R, Lobban F, Bucci S, et al
    Social media and its relationship with mood, self-esteem and paranoia in psychosis.
    Acta Psychiatr Scand. 2018 Sep 10. doi: 10.1111/acps.12953.
    PubMed     Text format     Abstract available


  7. KUBO K, Fleischhacker WW, Suzuki T, Yasui-Furukori N, et al
    Placebo effects in adult and adolescent patients with schizophrenia: combined analysis of nine RCTs.
    Acta Psychiatr Scand. 2018 Sep 9. doi: 10.1111/acps.12960.
    PubMed     Text format     Abstract available


    August 2018
  8. OSTERGAARD SD, Foldager L, Mors O, Bech P, et al
    The validity and sensitivity of PANSS-6 in treatment-resistant schizophrenia.
    Acta Psychiatr Scand. 2018 Aug 30. doi: 10.1111/acps.12952.
    PubMed     Text format     Abstract available


  9. ORHAN F, Schwieler L, Fatouros-Bergman H, Malmqvist A, et al
    Increased number of monocytes and plasma levels of MCP-1 and YKL-40 in first-episode psychosis.
    Acta Psychiatr Scand. 2018 Aug 21. doi: 10.1111/acps.12944.
    PubMed     Text format     Abstract available


  10. AMORETTI S, Cabrera B, Torrent C, Mezquida G, et al
    Cognitive reserve as an outcome predictor: first-episode affective versus non-affective psychosis.
    Acta Psychiatr Scand. 2018 Aug 14. doi: 10.1111/acps.12949.
    PubMed     Text format     Abstract available


  11. ARICAN I, Bass N, Neelam K, Wolfe K, et al
    Prevalence of attention deficit hyperactivity disorder symptoms in patients with schizophrenia.
    Acta Psychiatr Scand. 2018 Aug 13. doi: 10.1111/acps.12948.
    PubMed     Text format     Abstract available


    July 2018
  12. BUCCI P, Galderisi S, Mucci A, Rossi A, et al
    Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition.
    Acta Psychiatr Scand. 2018 Jul 8. doi: 10.1111/acps.12938.
    PubMed     Text format     Abstract available


  13. DONDE C, Vignaud P, Poulet E, Brunelin J, et al
    Management of depression in patients with schizophrenia spectrum disorders: a critical review of international guidelines.
    Acta Psychiatr Scand. 2018 Jul 4. doi: 10.1111/acps.12939.
    PubMed     Text format     Abstract available


  14. MACCABE JH
    It is time to start taking tobacco seriously as a risk factor for psychosis: self-medication cannot explain the association.
    Acta Psychiatr Scand. 2018;138:3-4.
    PubMed     Text format    


    June 2018
  15. TANSKANEN A, Tiihonen J, Taipale H
    Mortality in schizophrenia: 30-year nationwide follow-up study.
    Acta Psychiatr Scand. 2018 Jun 13. doi: 10.1111/acps.12913.
    PubMed     Text format     Abstract available


    April 2018
  16. RIEHLE M, Mehl S, Lincoln TM
    The specific social costs of expressive negative symptoms in schizophrenia: reduced smiling predicts interactional outcome.
    Acta Psychiatr Scand. 2018 Apr 17. doi: 10.1111/acps.12892.
    PubMed     Text format     Abstract available


  17. SUETANI S, Siskind D, Scott JG, McGrath JJ, et al
    Disentangling schizophrenia spectrum disorders.
    Acta Psychiatr Scand. 2018;137:365-366.
    PubMed     Text format    


    March 2018
  18. KRYNICKI CR, Upthegrove R, Deakin JFW, Barnes TRE, et al
    The relationship between negative symptoms and depression in schizophrenia: a systematic review.
    Acta Psychiatr Scand. 2018 Mar 13. doi: 10.1111/acps.12873.
    PubMed     Text format     Abstract available


  19. GALLING B, Vernon JA, Pagsberg AK, Wadhwa A, et al
    Efficacy and safety of antidepressant augmentation of continued antipsychotic treatment in patients with schizophrenia.
    Acta Psychiatr Scand. 2018;137:187-205.
    PubMed     Text format     Abstract available


    February 2018
  20. MUSTONEN A, Ahokas T, Nordstrom T, Murray GK, et al
    Smokin` hot: adolescent smoking and the risk of psychosis.
    Acta Psychiatr Scand. 2018 Feb 18. doi: 10.1111/acps.12863.
    PubMed     Text format     Abstract available


  21. MA CH, Chang SS, Tsai HJ, Gau SS, et al
    Comparative effect of antipsychotics on risk of self-harm among patients with schizophrenia.
    Acta Psychiatr Scand. 2018 Feb 11. doi: 10.1111/acps.12857.
    PubMed     Text format     Abstract available


    January 2018
  22. ROHDE C, Polcwiartek C, Kragholm K, Ebdrup BH, et al
    Adverse cardiac events in out-patients initiating clozapine treatment: a nationwide register-based study.
    Acta Psychiatr Scand. 2018;137:47-53.
    PubMed     Text format     Abstract available


    December 2017
  23. BELBASIS L, Kohler CA, Stefanis N, Stubbs B, et al
    Risk factors and peripheral biomarkers for schizophrenia spectrum disorders: an umbrella review of meta-analyses.
    Acta Psychiatr Scand. 2017 Dec 30. doi: 10.1111/acps.12847.
    PubMed     Text format     Abstract available


  24. LIN CH, Lin HS, Lin SC, Kuo CC, et al
    Early improvement in PANSS-30, PANSS-8, and PANSS-6 scores predicts ultimate response and remission during acute treatment of schizophrenia.
    Acta Psychiatr Scand. 2017 Dec 27. doi: 10.1111/acps.12849.
    PubMed     Text format     Abstract available


    November 2017
  25. KRAKAUER K, Nordentoft M, Glenthoj BY, Raghava JM, et al
    White matter maturation during 12 months in individuals at ultra-high-risk for psychosis.
    Acta Psychiatr Scand. 2017 Nov 16. doi: 10.1111/acps.12835.
    PubMed     Text format     Abstract available


  26. MIZUNO Y, Hofer A, Frajo-Apor B, Wartelsteiner F, et al
    Religiosity and psychological resilience in patients with schizophrenia and bipolar disorder: an international cross-sectional study.
    Acta Psychiatr Scand. 2017 Nov 15. doi: 10.1111/acps.12838.
    PubMed     Text format     Abstract available


    October 2017
  27. MCCUTCHEON R, Beck K, D'Ambrosio E, Donocik J, et al
    Antipsychotic plasma levels in the assessment of poor treatment response in schizophrenia.
    Acta Psychiatr Scand. 2017 Oct 26. doi: 10.1111/acps.12825.
    PubMed     Text format     Abstract available


    September 2017
  28. STEGMAYER K, Stettler M, Strik W, Federspiel A, et al
    Resting state perfusion in the language network is linked to formal thought disorder and poor functional outcome in schizophrenia.
    Acta Psychiatr Scand. 2017 Sep 2. doi: 10.1111/acps.12790.
    PubMed     Text format     Abstract available


    August 2017
  29. FAN X, Song X, Zhao M, Jarskog LF, et al
    The effect of adjunctive telmisartan treatment on psychopathology and cognition in patients with schizophrenia.
    Acta Psychiatr Scand. 2017 Aug 29. doi: 10.1111/acps.12799.
    PubMed     Text format     Abstract available


  30. EBDRUP BH, Ishoy PL, Fagerlund B, Broberg BV, et al
    'No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia': authors' response.
    Acta Psychiatr Scand. 2017 Aug 28. doi: 10.1111/acps.12795.
    PubMed     Text format    


  31. SPERANDEO R, Maldonato MN, Dell'Orco S
    Comment on 'No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia'.
    Acta Psychiatr Scand. 2017 Aug 4. doi: 10.1111/acps.12782.
    PubMed     Text format    


    July 2017
  32. KIM JS, Park CM, Choi JA, Park E, et al
    The association between season of birth, age at onset, and clozapine use in schizophrenia.
    Acta Psychiatr Scand. 2017 Jul 25. doi: 10.1111/acps.12776.
    PubMed     Text format     Abstract available


    June 2017
  33. CULLEN B, Smith DJ, Deary IJ, Evans JJ, et al
    The 'cognitive footprint' of psychiatric and neurological conditions: cross-sectional study in the UK Biobank cohort.
    Acta Psychiatr Scand. 2017;135:593-605.
    PubMed     Text format     Abstract available


    May 2017
  34. DEBOST JC, Debost M, Grove J, Mors O, et al
    COMT Val158Met and MTHFR C677T moderate risk of schizophrenia in response to childhood adversity.
    Acta Psychiatr Scand. 2017 May 29. doi: 10.1111/acps.12761.
    PubMed     Text format     Abstract available


  35. WEISS SRB, Blanco C, Wargo EM
    Clarifying the link between cannabis use and risk for psychosis.
    Acta Psychiatr Scand. 2017 May 29. doi: 10.1111/acps.12764.
    PubMed     Text format    


  36. WALTON E, Hibar DP, van Erp TG, Potkin SG, et al
    Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium.
    Acta Psychiatr Scand. 2017;135:439-447.
    PubMed     Text format     Abstract available


  37. VERDOUX H, Pambrun E, Tournier M, Bezin J, et al
    Risk of discontinuation of antipsychotic long-acting injections vs. oral antipsychotics in real-life prescribing practice: a community-based study.
    Acta Psychiatr Scand. 2017;135:429-438.
    PubMed     Text format     Abstract available


    March 2017
  38. NUNEZ C, Paipa N, Senior C, Coromina M, et al
    Global brain asymmetry is increased in schizophrenia and related to avolition.
    Acta Psychiatr Scand. 2017 Mar 23. doi: 10.1111/acps.12723.
    PubMed     Text format     Abstract available


    February 2017
  39. JAKOBSEN MI, Larsen JR, Svensson CK, Johansen SS, et al
    The significance of sampling time in therapeutic drug monitoring of clozapine.
    Acta Psychiatr Scand. 2017;135:159-169.
    PubMed     Text format     Abstract available


  40. KOHLER O, Petersen L, Mors O, Mortensen PB, et al
    Infections and exposure to anti-infective agents and the risk of severe mental disorders: a nationwide study.
    Acta Psychiatr Scand. 2017;135:97-105.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: